Stefanie de Boer
0000-0002-7532-2536
1 paper found
Refreshing results…
Angiogenic T cells are decreased in people with type 2 diabetes mellitus and recruited by the dipeptidyl peptidase‐4 inhibitor Linagliptin. A subanalysis from a randomized, placebo controlled trial (RELEASE study)
Missing publications? Search for publications with a matching author name.